Related Experiment Video
Updated: Jan 7, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
Flow Cytometry Analysis of IFNγ-Induced PD-L1 Cell Surface Expression in Ovarian Cancer Cells
Sveta Padmanabhan1, Yue Zou1, Ivana Vancurova1
1Department of Biology, St. John's University, Queens, NY, USA.
This study details a flow cytometry method to measure programmed cell death protein ligand 1 (PD-L1) on ovarian cancer cells. This can help predict patient response to cancer immunotherapies targeting PD-1/PD-L1 signaling.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Immunotherapies targeting the PD-1/PD-L1 pathway offer promise for cancer treatment.
- However, many patients do not respond to or develop resistance against these therapies.
- Surface expression of PD-L1 on cancer cells is a key factor influencing treatment response.
Purpose of the Study:
- To establish a reliable flow cytometry protocol for analyzing PD-L1 expression.
- To investigate PD-L1 induction by IFNγ in ovarian cancer cells.
- To facilitate the assessment of PD-L1 as a biomarker for immunotherapy response.
Main Methods:
- Development of a flow cytometry protocol.
- Utilizing an antibody specific to the extracellular domain of PD-L1.
- Induction of PD-L1 expression using IFNγ in ovarian cancer cell lines.
Main Results:
- A robust method for quantifying cell surface PD-L1 was established.
- IFNγ effectively induced PD-L1 expression on ovarian cancer cells.
- The protocol allows for precise measurement of PD-L1 levels.
Conclusions:
- The described flow cytometry protocol enables accurate analysis of PD-L1 surface expression.
- This method can aid in identifying patients likely to benefit from PD-1/PD-L1 blockade therapies.
- Understanding PD-L1 expression is crucial for optimizing cancer immunotherapy strategies.
More Related Videos
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019